![](/img/cover-not-exists.png)
Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1
Griffiths, Christopher E. M., Papp, Kim A., Song, Michael, Miller, Megan, You, Yin, Shen, Yaung-Kaung, Han, Chenglong, Blauvelt, AndrewJournal:
Journal of Dermatological Treatment
DOI:
10.1080/09546634.2020.1782817
Date:
July, 2020
File:
PDF, 2.16 MB
2020